A Cystic Fibrosis
Research Development Program at the Johns Hopkins University
was established in 1989. This program conducts high
caliber research and provides training focused directly
on understanding and correcting the defect in CF. Our
goal is to reverse or amend the course of the disease
by contributing to the collective understanding of the
molecular defect in CF. The Johns Hopkins University
provides an excellent environment to maintain this RDP
because of the commitment of researchers to focus their
research efforts on the study of CF. The expertise of
these researchers is in the areas of biochemistry, biophysics,
cell biology, clinical research, and molecular biology.
The CF RDP functions as a focal point for an interdisciplinary
approach to the study of CF. A major function is to
attract and train new investigators. By providing funding
for promising new initiatives, the RDP has aided members
of our group to obtain funding for CF related research
from sources other than the CF Foundation. The RDP grew
out of an integration of the basic and clinical sciences
with the common goal of helping CF patients by developing
new therapies. A particular strength is the collaborative
interaction of senior and independent principal investigators
from both clinical and basic science departments. This
combination of independence and collaboration stems
from the environment at JHU where independent thought
and scientific discovery are valued very highly.
Who
we are?
The
mission of the center is to increase awareness, perform
research and work towards a cure for cystic fibrosis.
